Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging.

Sheeran PS, Wong VP, Luois S, McFarland RJ, Ross WD, Feingold S, Matsunaga TO, Dayton PA.

Ultrasound Med Biol. 2011 Sep;37(9):1518-30. doi: 10.1016/j.ultrasmedbio.2011.05.021. Epub 2011 Jul 19.

2.

Effects of microchannel confinement on acoustic vaporisation of ultrasound phase change contrast agents.

Lin S, Zhang G, Leow CH, Tang MX.

Phys Med Biol. 2017 Aug 7;62(17):6884-6898. doi: 10.1088/1361-6560/aa8076.

PMID:
28718774
3.

Pulse sequences for uniform perfluorocarbon droplet vaporization and ultrasound imaging.

Puett C, Sheeran PS, Rojas JD, Dayton PA.

Ultrasonics. 2014 Sep;54(7):2024-33. doi: 10.1016/j.ultras.2014.05.013. Epub 2014 Jun 6.

PMID:
24965563
4.

Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents.

Sheeran PS, Rojas JD, Puett C, Hjelmquist J, Arena CB, Dayton PA.

Ultrasound Med Biol. 2015 Mar;41(3):814-31. doi: 10.1016/j.ultrasmedbio.2014.10.020. Epub 2015 Jan 22.

5.

Investigation of vaporized submicron perfluorocarbon droplets as an ultrasound contrast agent.

Reznik N, Williams R, Burns PN.

Ultrasound Med Biol. 2011 Aug;37(8):1271-9. doi: 10.1016/j.ultrasmedbio.2011.05.001.

PMID:
21723449
6.

Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons.

Sheeran PS, Luois SH, Mullin LB, Matsunaga TO, Dayton PA.

Biomaterials. 2012 Apr;33(11):3262-9. doi: 10.1016/j.biomaterials.2012.01.021. Epub 2012 Jan 29.

7.

Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound.

Sheeran PS, Luois S, Dayton PA, Matsunaga TO.

Langmuir. 2011 Sep 6;27(17):10412-20. doi: 10.1021/la2013705. Epub 2011 Jul 28.

8.

Phase-change contrast agents for imaging and therapy.

Sheeran PS, Dayton PA.

Curr Pharm Des. 2012;18(15):2152-65. Review.

9.

Phase-shift perfluorocarbon agents enhance high intensity focused ultrasound thermal delivery with reduced near-field heating.

Phillips LC, Puett C, Sheeran PS, Wilson Miller G, Matsunaga TO, Dayton PA.

J Acoust Soc Am. 2013 Aug;134(2):1473-82. doi: 10.1121/1.4812866. Erratum in: J Acoust Soc Am. 2013 Dec;134(6):4575.

10.

Size reduction of cosolvent-infused microbubbles to form acoustically responsive monodisperse perfluorocarbon nanodroplets.

Seo M, Williams R, Matsuura N.

Lab Chip. 2015 Sep 7;15(17):3581-90. doi: 10.1039/c5lc00315f. Epub 2015 Jul 29.

PMID:
26220563
11.

Targeted Transthoracic Acoustic Activation of Systemically Administered Nanodroplets to Detect Myocardial Perfusion Abnormalities.

Porter TR, Arena C, Sayyed S, Lof J, High RR, Xie F, Dayton PA.

Circ Cardiovasc Imaging. 2016 Jan;9(1). pii: e003770. doi: 10.1161/CIRCIMAGING.115.003770.

12.

On the acoustic properties of vaporized submicron perfluorocarbon droplets.

Reznik N, Lajoinie G, Shpak O, Gelderblom EC, Williams R, de Jong N, Versluis M, Burns PN.

Ultrasound Med Biol. 2014 Jun;40(6):1379-84. doi: 10.1016/j.ultrasmedbio.2013.11.025. Epub 2014 Jan 22.

PMID:
24462162
13.

Quantifying activation of perfluorocarbon-based phase-change contrast agents using simultaneous acoustic and optical observation.

Li S, Lin S, Cheng Y, Matsunaga TO, Eckersley RJ, Tang MX.

Ultrasound Med Biol. 2015 May;41(5):1422-31. doi: 10.1016/j.ultrasmedbio.2014.12.021. Epub 2015 Feb 2.

14.

Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro.

Marshalek JP, Sheeran PS, Ingram P, Dayton PA, Witte RS, Matsunaga TO.

J Control Release. 2016 Dec 10;243:69-77. doi: 10.1016/j.jconrel.2016.09.010. Epub 2016 Sep 26.

15.

The efficiency and stability of bubble formation by acoustic vaporization of submicron perfluorocarbon droplets.

Reznik N, Shpak O, Gelderblom EC, Williams R, de Jong N, Versluis M, Burns PN.

Ultrasonics. 2013 Sep;53(7):1368-76. doi: 10.1016/j.ultras.2013.04.005. Epub 2013 Apr 16.

PMID:
23652262
16.

Image-Guided Ultrasound Characterization of Volatile Sub-Micron Phase-Shift Droplets in the 20-40 MHz Frequency Range.

Sheeran PS, Daghighi Y, Yoo K, Williams R, Cherin E, Foster FS, Burns PN.

Ultrasound Med Biol. 2016 Mar;42(3):795-807. doi: 10.1016/j.ultrasmedbio.2015.11.012. Epub 2015 Dec 24.

PMID:
26725168
17.

Vaporization dynamics of volatile perfluorocarbon droplets: a theoretical model and in vitro validation.

Doinikov AA, Sheeran PS, Bouakaz A, Dayton PA.

Med Phys. 2014 Oct;41(10):102901. doi: 10.1118/1.4894804.

18.

Acoustic Behavior of a Reactivated, Commercially Available Ultrasound Contrast Agent.

Choudhury SA, Xie F, Dayton PA, Porter TR.

J Am Soc Echocardiogr. 2017 Feb;30(2):189-197. doi: 10.1016/j.echo.2016.10.015. Epub 2016 Dec 6.

PMID:
27939052
19.

Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle.

Sheeran PS, Streeter JE, Mullin LB, Matsunaga TO, Dayton PA.

Ultrasound Med Biol. 2013 May;39(5):893-902. doi: 10.1016/j.ultrasmedbio.2012.11.017. Epub 2013 Feb 27.

20.

Characterization of submicron phase-change perfluorocarbon droplets for extravascular ultrasound imaging of cancer.

Williams R, Wright C, Cherin E, Reznik N, Lee M, Gorelikov I, Foster FS, Matsuura N, Burns PN.

Ultrasound Med Biol. 2013 Mar;39(3):475-89. doi: 10.1016/j.ultrasmedbio.2012.10.004. Epub 2013 Jan 11.

PMID:
23312960

Supplemental Content

Support Center